JP Morgan Reinstates Overweight on Immunocore Holdings, Announces $50 Price Target
Benzinga Newsdesk 2 months ago
NewsInitiationAnalyst RatingsPrice Target
JP Morgan analyst Jessica Fye reinstates Immunocore Holdings (NASDAQ:IMCR) with a Overweight and announces $50 price target.
JP Morgan analyst Jessica Fye reinstates Immunocore Holdings (NASDAQ:IMCR) with a Overweight and announces $50 price target.